You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

5-HT7 receptor

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

Enrolling by invitation
  • Chronic Kidney Diseases
  • Aurora, Colorado
  • +5 more
Oct 18, 2022

Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)

Not yet recruiting
  • Gastrooesophageal Cancer
  • Trastuzumab deruxtecan
  • Southampton, Hampshire, United Kingdom
  • +16 more
Jul 27, 2023

Heart Failure Trial in Worldwide (Spironolacton)

Completed
  • Heart Failure
  • Corbeil-Essonnes, France
  • +8 more
Mar 7, 2022

Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)

Recruiting
  • Breast Cancer
  • Bowral, New South Wales, Australia
  • +37 more
Aug 8, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Active, not recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +20 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Type 1 Diabetes With Diabetic Nephropathy Trial in Worldwide (Sotagliflozin, Ambrisentan, Ambrisentan and Sotagliflozin)

Not yet recruiting
  • Type 1 Diabetes Mellitus With Diabetic Nephropathy
  • Aurora, Colorado
  • +6 more
Oct 2, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Birmingham, Alabama
  • +12 more
Nov 9, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Constipation Trial (acupuncture, Prucalopride)

Completed
Has Results
  • Constipation
  • (no location specified)
Feb 24, 2021

Intermittent Explosive Disorder Trial in Columbus (Pimavanserin 34 mg, Placebo)

Not yet recruiting
  • Intermittent Explosive Disorder
  • Pimavanserin 34 mg
  • Placebo
  • Columbus, Ohio
    The Ohio State University College of Medicine
May 31, 2023

Breast Cancer, Breast Carcinoma, Breast Tumors Trial in Canada, United Kingdom, United States (Letrozole, palbociclib)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Long Beach, California
  • +51 more
Jan 4, 2022

Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part

Completed
  • Esophageal Squamous Cell Carcinoma
  • Nivolumab
  • Truro, Cornwall, United Kingdom
  • +35 more
May 18, 2022

Cabozantinib Post First-line Immuno-oncology Checkpoint

Completed
  • Advanced Renal Cell Carcinoma (aRCC)
    • Glasgow, United Kingdom
    • +8 more
    Jun 30, 2022

    Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Capivasertib, Matched Capivasertib Placebo,

    Recruiting
    • Locally Advanced (Inoperable) or Metastatic Breast Cancer
    • Los Angeles, California
    • +76 more
    Nov 25, 2022

    HPV Infection, CIN1 Trial in Belgium, Estonia, United Kingdom (ChAdOx1-HPV, MVA-HPV, Placebo)

    Active, not recruiting
    • HPV Infection
    • CIN1
    • ChAdOx1-HPV
    • +2 more
    • Antwerp, Belgium
    • +15 more
    Jan 9, 2023

    Coronavirus Infection, COVID-19 Trial in Saint Petersburg (Low dose BCD-250 injection, High dose BCD-250 injection, Low dose or

    Recruiting
    • Coronavirus Infection
    • COVID-19
    • Low dose BCD-250 injection
    • +3 more
    • Saint Petersburg, Russian Federation
    • +1 more
    Sep 7, 2021

    Oropharyngeal Cancer Trial in United Kingdom (Cisplatin, Durvalumab, Radiotherapy)

    Recruiting
    • Oropharyngeal Cancer
    • Exeter, Devon, United Kingdom
    • +32 more
    Nov 29, 2021

    Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

    Active, not recruiting
    • Breast Neoplasms
    • +7 more
    • Goodyear, Arizona
    • +38 more
    Jun 29, 2022

    Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Pembrolizumab)

    Not yet recruiting
    • Breast Cancer
    • Jonesboro, Arkansas
    • +142 more
    Oct 31, 2023

    Subarachnoid Hemorrhage Trial in United Kingdom (IL-1Ra, IL-1Ra Placebo)

    Recruiting
    • Subarachnoid Hemorrhage
    • Plymouth, Devon, United Kingdom
    • +11 more
    May 16, 2022

    Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive, Subarachnoid Hemorrhage Trial in United Kingdom (Apixaban,

    Completed
    • Intracranial Hemorrhages
    • +8 more
    • Edinburgh, Midlothian, United Kingdom
    • +66 more
    Mar 31, 2022

    Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

    Active, not recruiting
    • Estrogen Receptor Negative
    • +15 more
    • Bellevue, Nebraska
    • +3 more
    Nov 30, 2022

    Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant

    Withdrawn
    • Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
    • +3 more
    • (no location specified)
    Oct 13, 2021

    Venous Leg Ulcer, Leg Ulcers Venous, Leg Ulcer Trial in United Kingdom (geko™ medical device)

    Active, not recruiting
    • Venous Leg Ulcer
    • +4 more
    • geko™ medical device
    • Southsea, Portsmouth, United Kingdom
    • +22 more
    Aug 4, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

    Not yet recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +14 more
    • Biopsy
    • +25 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jul 12, 2022